HomeInsightsShare Holding

Marksans Pharma Ltd Share Holding Pattern

Marksans Pharma Ltd Share Holding Pattern

stocks purchased

₹ 11.9 Cr

Volume transacted

stocks purchased

434.7 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Promoters Holdings Over Time

Key Highlights

  • Promoters increased their stake in the company by 0.02% from March 2024 to June 2024. FIIs/FPIs increased their stake in the company by 3.02% from March 2024 to June 2024.
  • Mutual funds decreased their stake in the company by 1.41% from March 2024 to June 2024.

Latest Shareholding

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024274.25
18 Sep 2024281.25
17 Sep 2024296.25
16 Sep 2024293.85
13 Sep 2024277.35
12 Sep 2024268.1
11 Sep 2024272.85
10 Sep 2024263.5
09 Sep 2024258.5
06 Sep 2024263

Marksans Pharma Ltd News Hub

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

21 Aug 202420:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

20 Aug 202414:37

News

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

20 Aug 202410:46

News

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed...

Read more

20 Aug 202414:48

News

Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr

Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...

Read more

14 Aug 202412:04

News

Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

02 Aug 202416:12

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for EPS of Marksans Pharma Ltd

On what factors does the shareholding pattern of Marksans Pharma Ltd change frequently?

The shareholding pattern of Marksans Pharma Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Marksans Pharma Ltd's shareholding pattern updated?

The Marksans Pharma Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Marksans Pharma Ltd?

Categories included in the shareholding pattern of Marksans Pharma Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Marksans Pharma Ltd important for investors?

The shareholding pattern of Marksans Pharma Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Marksans Pharma Ltd?

The latest shareholding pattern of Marksans Pharma Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*